Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Xeris Pharmaceuticals Inc
(NQ:
XERS
)
2.930
-0.050 (-1.68%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Xeris Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
Next >
Xeris Biopharma Appoints Ricki Fairley to Board of Directors
March 29, 2023
From
Xeris Biopharma Holdings
Via
Business Wire
Xeris Biopharma Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides 2023 Financial Guidance
March 08, 2023
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Xeris Biopharma to Report Fourth Quarter and Full-Year 2022 Financial Results on March 8, 2023
February 23, 2023
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Xeris Biopharma to Participate in the SVB Securities Global Biopharma Conference 2023
February 02, 2023
From
Xeris Biopharma, Inc.
Via
Business Wire
Earnings Scheduled For March 8, 2023
March 08, 2023
Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million.
Via
Benzinga
Xeris Pharmaceuticals's Earnings Outlook
March 07, 2023
Via
Benzinga
Xeris Biopharma Announces FDA Grants Orphan-drug Exclusivity for Recorlev®
January 30, 2023
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Xeris Biopharma to Present at 41st Annual J.P. Morgan Healthcare Conference
January 05, 2023
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Xeris Biopharma Updates Its Outlook For 2022
January 05, 2023
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Thursday
January 05, 2023
On Thursday, 63 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 04, 2023
On Wednesday, 35 companies reached new 52-week lows.
Via
Benzinga
Xeris Biopharma Announces Plans for a Phase II Dose-Finding Study for Its Investigational Subcutaneous (SC) Levothyroxine (XP-8121) as Replacement Therapy for Hypothyroidism
December 15, 2022
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Xeris Biopharma Announces Research Collaboration and Option Agreement With Horizon Therapeutics plc for XeriJect™ Formulation of Teprotumumab
November 23, 2022
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Xeris Biopharma Reports Third Quarter 2022 Financial Results and Recent Events
November 09, 2022
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Earnings Scheduled For November 9, 2022
November 09, 2022
Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly earnings at $0.11 per share on revenue of $103.46 million.
Via
Benzinga
Xeris Biopharma to Report Third Quarter 2022 Financial Results on November 9, 2022
November 02, 2022
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Xeris Biopharma Announces Results of the Extended Evaluation of Recorlev® (Levoketoconazole) From the Phase 3 Sonics Study Published in the European Journal of Endocrinology
November 01, 2022
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
10 Best Medical Stocks Under $5
October 29, 2022
The medical industry is one of the most lucrative sectors globally, and it is one that sees the highest spending in terms of research and development, and breakthrough advances through keeping up the...
Via
Talk Markets
Xeris Biopharma Posts Encouraging Data From Reformulated Thyroid Hormone Deficiency Treatment In Healthy Participants
October 20, 2022
Via
Benzinga
Xeris Biopharma Announces Positive Topline Phase 1 Clinical Data of Its Investigational Subcutaneous (SC) Levothyroxine (XP-8121); Hosts Conference Call and Webcast
October 20, 2022
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Xeris Biopharma Reports Second Quarter Financial Results and Upcoming Events
August 10, 2022
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
121 Stocks That Hit Their 52-Week Low
October 14, 2022
New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows.
Via
Benzinga
Earnings Scheduled For August 10, 2022
August 10, 2022
Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is estimated to report earnings for its second quarter.
Via
Benzinga
Xeris Biopharma to Report Second Quarter 2022 Financial Results on August 10, 2022
August 03, 2022
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Xeris’ Commercialization Partner for Ogluo®, Tetris Pharma Ltd, to Be Acquired by Arecor Therapeutics
August 01, 2022
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
June 16, 2022
It's time for another breakdown of the biggest pre-market stock movers as we go over the latest news for Thursday morning.
Via
InvestorPlace
27 Stocks Moving in Thursday's Pre-Market Session
June 16, 2022
Gainers Heart Test Laboratories, Inc. (NASDAQ: HSCS) rose 92.9% to $3.28 in pre-market trading following’s Wednesday IPO.
Via
Benzinga
Xeris Announces Full Results From the Logics Study of Recorlev® and Presentation of New Burden of Illness in Cushing’s Syndrome Data at AACE Annual Meeting May 12-14
May 12, 2022
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
73 Biggest Movers From Yesterday
May 17, 2022
Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares jumped 65.9% to close at $2.77 on Monday after gaining around 10% on Friday.
Via
Benzinga
The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine
May 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.